Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis
- PMID: 21083941
- PMCID: PMC2998474
- DOI: 10.1186/1477-5956-8-59
Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis
Abstract
Background: Streptomycin (SM) is a broad spectrum antibiotic and is an important component of any anti-tuberculosis therapy regimen. Several mechanisms have been proposed to explain the emergence of resistance but still our knowledge is inadequate. Proteins form a very complex network and drugs are countered by their modification/efflux or over expression/modification of targets. As proteins manifest most of the biological processes, these are attractive targets for developing drugs, immunodiagnostics or therapeutics. The aim of present study was to analyze and compare the protein profile of whole cell extracts from Mycobacterium tuberculosis clinical isolates susceptible and resistant to SM.
Results: Two-dimensional gel electrophoresis (2DE) and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry was employed for analyzing the protein profiles. Homology and in silico characterization for identified proteins was assessed using BLAST, InterProScan and KEGG database searches. Computational studies on the possible interactions between SM and identified proteins were carried out by a battery of online servers and softwares, namely, CLUSTALW (KEGG), I-TASSER, VMD, PatchDock and FireDock. On comparing 2DE patterns, nine proteins were found consistently overexpressed in SM resistant isolates and were identified as Rv0350, Rv0440, Rv1240, Rv3075c, Rv2971, Rv3028c, Rv2145c, Rv2031c and Rv0569. In silico docking analysis showed significant interactions of SM with essential (Rv0350, Rv0440 and Rv2971) and non essential (Rv1240, Rv3075c and Rv2031c) genes.
Conclusions: The computational results suggest high protein binding affinity of SM and suggested many possible interactions between identified proteins and the drug. Bioinformatic analysis proves attributive for analysis of diversity of proteins identified by whole proteome analysis. In-depth study of the these proteins will give an insight into probable sites of drug action other than established primary sites and hence may help in search of novel chemotherapeutic agents at these new sites as inhibitors.
Figures




Similar articles
-
Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin.J Proteomics. 2013 Dec 6;94:68-77. doi: 10.1016/j.jprot.2013.08.025. Epub 2013 Sep 12. J Proteomics. 2013. PMID: 24036035
-
Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis.Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S123-S124. doi: 10.1016/j.ijmyco.2016.10.028. Epub 2016 Nov 16. Int J Mycobacteriol. 2016. PMID: 28043501
-
Secretory Proteome Analysis of Streptomycin-Resistant Mycobacterium tuberculosis Clinical Isolates.SLAS Discov. 2017 Dec;22(10):1229-1238. doi: 10.1177/2472555217698428. Epub 2017 Mar 17. SLAS Discov. 2017. PMID: 28314116
-
Streptomycin induced protein expression analysis in Mycobacterium tuberculosis by two-dimensional gel electrophoresis & mass spectrometry.Indian J Med Res. 2010 Oct;132:400-8. Indian J Med Res. 2010. PMID: 20966518
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
Proteomics Analysis of Three Different Strains of Mycobacterium tuberculosis under In vitro Hypoxia and Evaluation of Hypoxia Associated Antigen's Specific Memory T Cells in Healthy Household Contacts.Front Microbiol. 2016 Sep 9;7:1275. doi: 10.3389/fmicb.2016.01275. eCollection 2016. Front Microbiol. 2016. PMID: 27667981 Free PMC article.
-
Potential Alternative Strategy against Drug Resistant Tuberculosis: A Proteomics Prospect.Proteomes. 2018 May 28;6(2):26. doi: 10.3390/proteomes6020026. Proteomes. 2018. PMID: 29843395 Free PMC article. Review.
-
Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.Front Microbiol. 2017 Dec 11;8:2452. doi: 10.3389/fmicb.2017.02452. eCollection 2017. Front Microbiol. 2017. PMID: 29321768 Free PMC article.
-
Molecular Analysis of Streptomycin Resistance Genes in Clinical Strains of Mycobacterium tuberculosis and Biocomputational Analysis of the MtGidB L101F Variant.Antibiotics (Basel). 2021 Jul 2;10(7):807. doi: 10.3390/antibiotics10070807. Antibiotics (Basel). 2021. PMID: 34356728 Free PMC article.
-
Metformin as Host-Directed Therapy for TB Treatment: Scoping Review.Front Microbiol. 2020 Apr 29;11:435. doi: 10.3389/fmicb.2020.00435. eCollection 2020. Front Microbiol. 2020. PMID: 32411100 Free PMC article.
References
-
- World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO Report. 2009. http://www.who.int/tb/publications/global_report/2009/pdf/full_report.pdf
-
- Franco H, Wowk PF, Silva CL, Trombone APF, Coelho-Castelo AAM, Oliver C, Jamur MC, Moretto EL, Bonato VLD. A DNA vaccine against tuberculosis based on the 65 kDa heat-shock protein differentially activates human macrophages and dendritic cells. Genet Vaccines Ther. 2008;6:3. doi: 10.1186/1479-0556-6-3. - DOI - PMC - PubMed
-
- Zhang Y, Telenti A. In: Molecular Genetics of Mycobacteria. Hatfull GF, Jacobs WR, editor. Washington DC: ASM Press; 2000. Genetics of drug resistance in Mycobacterium tuberculosis; pp. 235–254.
-
- Ulger M, Aslan G, Emekdas G, Tezcan S, Serin MS. Investigation of rpsL and rrs gene region mutations in streptomycin resistant Mycobacterium tuberculosis complex isolates. Mikrobiyol Bul. 2009;43(1):115–120. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials